There is a need for new biomarkers of atherosclerotic cardiovascular disease (ACVD), the
main cause of death globally. Ceramides, a class of potent bioactive lipid mediators, have …

Background Hypertrophic cardiomyopathy (HCM) is caused by rare variants in sarcomere-encoding
genes, but little is known about the clinical significance of these variants in the …

Purpose To characterize the genetic architecture of left ventricular noncompaction (LVNC)
and investigate the extent to which it may represent a distinct pathology or a secondary …

Understanding the penetrance of pathogenic variants identified as secondary findings (SFs)
is of paramount importance with the growing availability of genetic testing. We estimated …

We were interested to read the recent update on recommendations for reporting of secondary
findings in clinical sequencing 1 and the accompanying updated list of genes in which …

Background: The complex genetics underlying human cardiac disease is evidenced by its
heterogenous manifestation, multigenic basis, and sporadic occurrence. These features have …

Motivation Data-independent acquisition mass spectrometry allows for comprehensive
peptide detection and relative quantification than standard data-dependent approaches. While …

Hypothesis The purpose of this study was to evaluate the 5-factor modified frailty index (mFI-5)
as a predictor of postoperative complications in patients undergoing total shoulder …

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an important cause of sudden cardiac
death associated with heterogeneous phenotypes, but there is no systematic framework …

Diastole is the sequence of physiological events that occur in the heart during ventricular
filling and principally depends on myocardial relaxation and chamber stiffness. Abnormal …